Skip to main navigation Skip to search Skip to main content

Three-Year Outcomes after Surgical Aortic Valve Replacement with a Bioprosthetic Valve from the Multi-Centre IMPACT Registry

  • Farhad Bakhtiary
  • , Peter Benedikt
  • , Nikolaos Bonaros
  • , Michael Borger
  • , Mirko Doss
  • , Richard Feyrer
  • , Jürg Grünenfelder
  • , Tamer Owais
  • , Seymur Karimli
  • , Ka Yan Lam
  • , Andreas Liebold
  • , Andreas Martens
  • , Parwis Massoudy
  • , Islam Batashev
  • , Jochen Pöling
  • , Maximilian Philipp Scherner
  • , Justus Strauch
  • , Matthias Thielmann
  • , Andreas Vötsch
  • , Thomas Walther
  • Alberto Weber, Stefan Wiesinger, Matthias Eden, Jürgen Kammler, Beate Botta, Nataliya Trushina, Anjaly Vijayan, Peter Bramlage*, Andreas Zierer
*Corresponding author for this work

Research output: Journal article (peer-reviewed) › Journal article

Abstract

Objectives To investigate 3-year outcomes of surgical aortic valve replacement using the INSPIRIS RESILIA aortic valve bioprosthesis in patients with severe aortic stenosis. Methods IMPACT registry is a prospective, multicentre, international registry with a 5-year follow-up. After 3 years, haemodynamic performance, all-cause mortality, and valve-related mortality were determined. Results A total of 556 patients who underwent surgical aortic valve replacement with the INSPIRIS RESILIA aortic valve were enrolled between December 2019 and June 2021. The mean age was 63.4 ± 8.5 years, 29.0% were female, with a EuroSCORE II of 2.2 ± 2.5% and an STS score of 1.7 ± 2.2%. Hypertension (66.2%), coronary artery disease (34.7%), and diabetes (18.4%) were the most common comorbidities. A total of 49.3% of patients underwent full sternotomy, 58.3% isolated aortic valve replacement. The most commonly implanted valve sizes were 23 mm (35.4%) and 25 mm (30.9%). At 3 years, overall survival was 91.0%, freedom from valve-related mortality was 97.5%, from prosthetic endocarditis 96.0%, from stroke 91.5%, from valve-related dysfunction 98.0%, from reintervention 96.2%, from structural valve deterioration stage 2 96.8%, and from stage 3 99.4%. The mean transvalvular gradient was 11.9 mmHg at 3 years, with an indexed effective orifice area of 0.8 cm2/m2. Functional class improved from 41.2% class III or IV at baseline to 5.7% at 3 years. Conclusions Three-year outcomes, including survival and haemodynamic and functional status after surgical aortic valve replacement using the INSPIRIS RESILIA bioprosthetic aortic valve, were reported in a real-world patient population with severe aortic stenosis. ClinicalTrials.gov NCT04053088.

Original languageEnglish
Article numberivag056
JournalInterdisciplinary cardiovascular and thoracic surgery
Volume41
Issue number3
DOIs
Publication statusPublished - 01 Mar 2026
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • aortic stenosis
  • INSPIRIS RESILIA
  • surgical aortic valve replacement
  • valve durability

ASJC Scopus subject areas

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Three-Year Outcomes after Surgical Aortic Valve Replacement with a Bioprosthetic Valve from the Multi-Centre IMPACT Registry'. Together they form a unique fingerprint.

Cite this